Home/ Stocks/ SER

Serina Therapeutics, Inc.

SER XASE

$2.43 -0.72 (-22.86%) ▼ 15-min delayed

Open

$2.93

High

$2.99

Low

$2.36

Volume

2.66M

Market Cap

$33.97M

About Serina Therapeutics, Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 13 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$0	$-4,595,000	$-0.45
Q2 2025	$130.0K	$-6,462,000	$-0.66
Q1 2025	$0	$-4,822,000	$-0.49
FY 2024	$56.0K	$-11,207,000	$-1.51

Related Market News

No specific coverage for SER yet. Check out our latest market news or earnings calendar.

Get SER Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Serina Therapeutics, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.